🇺🇸 Moderate-Dose Cannabidiol in United States

FDA authorised Moderate-Dose Cannabidiol on 25 June 2018

Marketing authorisation

FDA — authorised 25 June 2018

  • Application: NDA210365
  • Marketing authorisation holder: JAZZ PHARMS RES
  • Local brand name: EPIDIOLEX
  • Indication: SOLUTION — ORAL
  • Status: approved

Read official source →

Frequently asked questions

Is Moderate-Dose Cannabidiol approved in United States?

Yes. FDA authorised it on 25 June 2018.

Who is the marketing authorisation holder for Moderate-Dose Cannabidiol in United States?

JAZZ PHARMS RES holds the US marketing authorisation.